Top

Published in:

Open Access 01-12-2021 | Streptococci | Protocol

Modes of transmission and attack rates of group A Streptococcal infection: a protocol for a systematic review and meta-analysis

Authors: Dylan D. Barth, Jessica Daw, Ruomei Xu, Stephanie Enkel, Janessa Pickering, Tracy McRae, Mark E. Engel, Jonathan Carapetis, Rosemary Wyber, Asha C. Bowen

Published in: Systematic Reviews | Issue 1/2021

Abstract

Background

Group A Streptococcus (Strep A) is an important cause of mortality and morbidity globally. This bacterium is responsible for a range of different infections and post-infectious sequelae. Summarising the current knowledge of Strep A transmission to humans will address gaps in the evidence and inform prevention and control strategies. The objective of this study is to evaluate the modes of transmission and attack rates of group A streptococcal infection in human populations.

Methods

This systematic review protocol was prepared according to the Preferred Reporting Items for Systematic reviews and Meta-analysis Protocols (PRISMA-P) 2015 Statement. Using a comprehensive search strategy to identify any transmission studies that have been published in English since 1980, full-text articles will be identified and considered for inclusion against predefined criteria. We will include all studies reporting on Strep A transmission, who have identified a mode of transmission, and who reported attack rates. Risk of bias will be appraised using an appropriate tool. Our results will be described narratively and where feasible and appropriate, a meta-analysis utilizing the random-effects model will be used to aggregate the incidence proportions (attack rates) for each mode of transmission. In addition, we will also evaluate the emm genotype variants of the M protein causing Strep A infection and the association with transmission routes and attack rates, if any, by setting, socioeconomic background and geographical regions.

Discussion

We anticipate that this review will contribute to elucidating Strep A modes of transmission which in turn, will serve to inform evidence-based strategies including environmental health activities to reduce the transmission of Strep A in populations at risk of severe disease.

Trial registration

Systematic review registration: PROSPERO (CRD42019138472).

Available only for authorised users

Carapetis JR, Steer AC, Mulholland EK, Weber M. The global burden of group A streptococcal diseases. Lancet Infect Dis. 2005;5(11):685–94. https://doi.org/10.1016/S1473-3099(05)70267-X.

Watkins DA, Johnson CO, Colquhoun SM, Karthikeyan G, Beaton A, Bukhman G, et al. Global, Regional, and National Burden of Rheumatic Heart Disease, 1990-2015. N Engl J Med. 2017;377(8):713–22. https://doi.org/10.1056/NEJMoa1603693.

Bowen AC, Tong SYC, Andrews RM, O’Meara IM, McDonald MI, Chatfield MD, et al. Short-course oral co-trimoxazole versus intramuscular benzathine benzylpenicillin for impetigo in a highly endemic region: an open-label, randomised, controlled, non-inferiority trial. Lancet. 2014;384(9960):2132–40. https://doi.org/10.1016/S0140-6736(14)60841-2.CrossRefPubMed

Cole C, Gazewood J. Diagnosis and treatment of impetigo. Am Fam Physician. 2007;75(6):859–64.PubMed

Gerber MA, Baltimore RS, Eaton CB, Gewitz M, Rowley AH, Shulman ST, et al. Prevention of rheumatic fever and diagnosis and treatment of acute streptococcal pharyngitis: a scientific statement from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease. Circulation. 2009;119(11):1541–51. https://doi.org/10.1161/CIRCULATIONAHA.109.191959.CrossRefPubMed

McMillan DJ, Dreze PA, Vu T, Bessen DE, Guglielmini J, Steer AC, et al. Updated model of group A Streptococcus M proteins based on a comprehensive worldwide study. Clin Microbiol Infect. 2013;19(5):E222–9. https://doi.org/10.1111/1469-0691.12134.CrossRefPubMedPubMedCentral

May PJ, Bowen AC, Carapetis JR. The inequitable burden of group A streptococcal diseases in Indigenous Australians. Med J Aust. 2016;205(5):201–3. https://doi.org/10.5694/mja16.00400.CrossRefPubMed

Bowen AC, Mahé A, Hay RJ, Andrews RM, Steer AC, Tong SYC, et al. The global epidemiology of impetigo: a systematic review of the population prevalence of impetigo and pyoderma. PLoS One. 2015;10(8):e0136789. https://doi.org/10.1371/journal.pone.0136789.CrossRefPubMedPubMedCentral

Wong SS, Yuen K. Streptococcus pyogenes and re-emergence of scarlet fever as a public health problem. Emerg Microbes Infect. 2012 Jul;1(7):e2. https://doi.org/10.1038/emi.2012.9.CrossRefPubMedPubMedCentral

10.

Steer AC, Law I, Matatolu L, Beall BW, Carapetis JR. Global emm type distribution of group A streptococci: systematic review and implications for vaccine development. Lancet Infect Dis. 2009;9(10):611–6 [cited 2014 Aug 17] Available from: http://www.ncbi.nlm.nih.gov/pubmed/19778763.CrossRefPubMed

11.

Towers RJ, Carapetis JR, Currie BJ, Davies MR, Walker MJ, Dougan G, et al. Extensive diversity of Streptococcus pyogenes in a remote human population reflects global-scale transmission rather than localised diversification. PLoS One. 2013/09/26. 2013;8(9):e73851.CrossRefPubMedPubMedCentral

12.

Bonita R, Beaglehole R, Kjellstrom T. Basic epidemiology. 2nd ed. Organisation WH, editor. 2006.

13.

Hamburger M Jr, Robertson OH. Expulsion of group A hemolytic streptococci in droplets and droplet nuclei by sneezing, coughing and talking. Am J Med. 1948;4(5):690–701. https://doi.org/10.1016/S0002-9343(48)90392-1.CrossRefPubMed

14.

Hamilton A. Dissemination of streptococci through invisible sputum: In relation to scarlet fever and sepsis. JAMA. 1905;XLIV(14):1108–11.CrossRef

15.

Hamburger M. Studies on the transmission of hemolytic streptoccus infections: II. Beta hemolytic streptococci in the saliva of person with positive throat cultures. J fof Infect Dis. 1944;75(1):71–8. https://doi.org/10.1093/infdis/75.1.71.CrossRef

16.

Hamburger M. Studies on the transmission of hemolytic streptococcus infections. I: Cross infections in army hospital wards. J Infect Dis. 1944;75(1):58–70. https://doi.org/10.1093/infdis/75.1.58.CrossRef

17.

Ross PW. Beta-haemolytic streptococci in saliva. J Hyg (Lond). 1971;69(3):347–53. https://doi.org/10.1017/S0022172400021586.CrossRef

18.

Morawska L. Droplet fate in indoor environments, or can we prevent the spread of infection? Indoor Air. 2006;16(5):335–47. https://doi.org/10.1111/j.1600-0668.2006.00432.x.CrossRefPubMed

19.

Hamburger M Jr. Transfer of beta hemolytic streptococci by shaking hands. Am J Med. 1947;2(1):23–5. https://doi.org/10.1016/0002-9343(47)90003-X.CrossRefPubMed

20.

\Mj H, Green MJ, Hamburger VG. The problem of the “dangerous carrier” of hemolytic streptococci 1: number of hemolytic streptococci expelled by carriers with positive and negative nose cultures. J Infect Dis. 1945;77:68–81.CrossRef

21.

Brown WA, Allison VD. Infection of the air of scarlet-fever wards with Streptococcus pyogenes. J Hyg. 1937;37(1):1–13. https://doi.org/10.1017/S0022172400034768.CrossRefPubMedPubMedCentral

22.

Lemon HM, Loosli CG, Hamburger M Jr. Transmission and control of respiratory diseases in army barracks: II. The spread of haemolytic streptococcal infections among enlisted personnel. J Fof Infect Dis. 1948;82(1):72–85. https://doi.org/10.1093/infdis/82.1.72.CrossRef

23.

Perry WD, Siegel AC, Rammelkamp CH Jr. Transmission of group A streptococci. II. The role of contaminated dust. Am J Hyg. 1957;66(1):96–101.PubMed

24.

White E. On the possible transmission of haemolytic streptococci by dust. Lancet. 1936;227(5878):941–4. https://doi.org/10.1016/S0140-6736(01)37346-4.CrossRef

25.

Ferrieri P, Dajani AS, Wannamaker LW, Chapman SS. Natural history of impetigo. I. Site sequence of acquisition and familial patterns of spread of cutaneous streptococci. J Clin Invest. 1972;51(11):2851–62. https://doi.org/10.1172/JCI107108.CrossRefPubMedPubMedCentral

26.

Hare R. Haemolytic streptococci in normal people and carriers. Lancet. 1941;237(6125):85–8. https://doi.org/10.1016/S0140-6736(00)95071-2.CrossRef

27.

Colebrook L, Maxted WR, Morris JA. The presence of haemolytic and other streptococci on human skin. J Pathol Bacteriol. 1935;41(3):521–7. https://doi.org/10.1002/path.1700410316.CrossRef

28.

Cruickshank JG, Lightfoot NF, Sugars KH, Colman G, Simmons MD, Tolliday J, et al. A large outbreak of streptococcal pyoderma in a military training establishment. J Hyg. 1982;89(1):9–21. https://doi.org/10.1017/S0022172400070492.CrossRefPubMedPubMedCentral

29.

Sarangi J, Rowsell R. A nursing home outbreak of group A streptococcal infection: case control study of environmental contamination. J Hosp Infect. 1995;30(2):162–4. https://doi.org/10.1016/0195-6701(95)90160-4.CrossRefPubMed

30.

Loosli CG, Lemon HM, Wise H, Robertson OH. Studies on the transmission and control of respiratory disease within Army Barracks: I. Hamolytic streptococcal contamination of the environment. J Infect Dis. 1948;82(1):59–71. https://doi.org/10.1093/infdis/82.1.59.CrossRefPubMed

31.

Lemon HM. The nasal carrier of beta-hemolytic streptococci. N Engl J Med. 1997;237:988–95.CrossRef

32.

Perry WD, Siegel AC, Rammelkamp CH Jr, Wannamaker LW, Marple EC. Transmission of group A streptococci. I. The role of contaminated bedding. Am J Hyg. 1957;66(1):85–95.PubMed

33.

Mackintosh CA, Hoffman PN. An extended model for transfer of micro-organisms via the hands: differences between organisms and the effect of alcohol disinfection. J Hyg. 1984;92(3):345–55. https://doi.org/10.1017/S0022172400064561.CrossRefPubMedPubMedCentral

34.

Greig JD, Todd ECD, Bartleson CA, Michaels BS. Outbreaks where food workers have been implicated in the spread of foodborne disease. Part 1. Description of the problem, methods, and agents involved. J Food Prot. 2007;70(7):1752–61. https://doi.org/10.4315/0362-028X-70.7.1752.CrossRefPubMed

35.

Wilson LG. The historical riddle of milk-borne scarlet fever. Bull Hist Med. 1986;60(3):321–42.PubMed

36.

Bassett DC. Hippelates flies and streptococcal skin infection in Trinidad. Trans R Soc Trop Med Hyg. 1970;64(1):138–47. https://doi.org/10.1016/0035-9203(70)90207-5.CrossRefPubMed

37.

Chifanzwa R. House Fly (Musca Domestica L.) Temporal and Spatial Immune Response to Streptococcus Pyogenes and Salmonella Typhimurium: role of pathogen density in bacterial fate, persistence and transmission. Vol. Master of, Department of Biology. Georgia Southern University; 2011.

38.

Cogen AL, Nizet V, Gallo RL. Skin microbiota: a source of disease or defence? Br J Dermatol. 2008;158(3):442–55. https://doi.org/10.1111/j.1365-2133.2008.08437.x.CrossRefPubMedPubMedCentral

39.

Yokchoo N, Patanarapeelert N, Patanarapeelert K. The effect of group A streptococcal carrier on the epidemic model of acute rheumatic fever. Theor Biol Med Model. 2019;16(1):1–9.CrossRef

40.

DeMuri GP, Wald ER. The group A streptococcal carrier state reviewed: Still an enigma. J Pediatric Infect Dis Soc. 2014;3(4):336–42. https://doi.org/10.1093/jpids/piu030.CrossRefPubMed

41.

Martin JM, Group A. Streptococci Among School-Aged Children: Clinical Characteristics and the Carrier State. Pediatrics. 2004;114(5):1212–9. https://doi.org/10.1542/peds.2004-0133.CrossRefPubMed

42.

Kaplan EL, Gastanaduy AS, Huwe BB. The role of the carrier in treatment failures after antibiotic for group A streptococci in the upper respiratory tract. J Lab Clin Med. 1981;98(3):326–35.PubMed

43.

Cockerill FR, MacDonald KL, Thompson RL, Roberson F, Kohner PC, Besser-Wiek J, et al. An outbreak of invasive group A streptococcal disease associated with high carriage rates of the invasive clone among school-aged children. JAMA. 1997;277(1):38–43. https://doi.org/10.1001/jama.1997.03540250046030.CrossRefPubMed

44.

Mazón A, Gil-Setas A, de la Gándara LJ S, Vindel A, Sáez-Nieto JA. Transmission of Streptococcus pyogenes causing successive infections in a family. Clin Microbiol Infect. 2003;9(6):554–9. https://doi.org/10.1046/j.1469-0691.2003.00567.x.CrossRefPubMed

45.

James WE, Badger GF, Dingle JH. A study of illness in a group of Cleveland families. XIX. The epidemiology of the acquisition of group A streptococci and of associated illnesses. N Engl J Med. 1960;262(14):687–94. https://doi.org/10.1056/NEJM196004072621401.CrossRefPubMed

46.

Musher DM. How contagious are common respiratory tract infections? N Engl J Med. 2003;348(13):1256–66. https://doi.org/10.1056/NEJMra021771.CrossRefPubMed

47.

Mearkle R, Saavedra-Campos M, Lamagni T, Usdin M, Coelho J, Chalker V, et al. Household transmission of invasive group A Streptococcus infections in England: A population-based study, 2009, 2011 to 2013. Eurosurveillance. 2017;22(19).

48.

Karthikeyan G, Guilherme L. Acute rheumatic fever. Lancet. 2018;392(10142):161–74. https://doi.org/10.1016/S0140-6736(18)30999-1.

49.

Noonan S, Zurynski YA, Currie BJ, McDonald M, Wheaton G, Nissen M, et al. A national prospective surveillance study of acute rheumatic fever in Australian children. Pediatr Infect Dis J. 2013;32(1):e26–32. https://doi.org/10.1097/INF.0b013e31826faeb3.CrossRefPubMed

50.

Culliford-Semmens N, Tilton E, Wilson N, Stirling J, Dougherty R, Gentles T, et al. The New Zealand familial echo study reveals high prevalence of rheumatic heart disease amongst parents and siblings of children with rheumatic fever: echocardiography should be offered to first degree relatives. J Paediatr Child Health. 2018;54(S2):6.

51.

Aliku T, Sable C, Scheel A, Tompsett A, Lwabi P, Okello E, et al. Targeted echocardiographic screening for latent rheumatic heart disease in Northern Uganda: Evaluating Familial Risk Following Identification of an Index Case. PLoS Negl Trop Dis. 2016;10(6):e0004727. https://doi.org/10.1371/journal.pntd.0004727.CrossRefPubMedPubMedCentral

52.

Coffey PM, Ralph AP, Krause VL. The role of social determinants of health in the risk and prevention of group A streptococcal infection, acute rheumatic fever and rheumatic heart disease: a systematic review. PLoS Negl Trop Dis. 2018;12(6):1–22.CrossRef

53.

Daneman N, McGeer A, Low DE, Tyrrell G, Simor AE, McArthur M, et al. Hospital-Acquired Invasive Group A Streptococcal Infections in Ontario, Canada, 1992-2000. Clin Infect Dis. 2005;41(3):334–42. https://doi.org/10.1086/431589.CrossRefPubMed

54.

Deutscher M, Schillie S, Gould C, Baumbach J, Mueller M, Avery C, et al. Investigation of a group A streptococcal outbreak among residents of a long-term acute care hospital. Clin Infect Dis. 2011;52(8):988–94. https://doi.org/10.1093/cid/cir084.CrossRefPubMed

55.

Thigpen MC, Richards CL, Lynfield R, Barrett NL, Harrison LH, Arnold KE, et al. Invasive group A streptococcal infection in older adults in long-term care facilities and the community, United States, 1998-2003. Emerg Infect Dis. 2007;13(12):1852–9. https://doi.org/10.3201/eid1312.070303.CrossRefPubMedPubMedCentral

56.

Trell K, Jörgensen J, Rasmussen M, Senneby E. Management of an outbreak of postpartum Streptococcus pyogenes emm75 infections. J Hosp Infect. 2020;105(4):752–6. https://doi.org/10.1016/j.jhin.2020.05.040.CrossRefPubMed

57.

Siegel JD. Pediatric Infection Prevention and Control. In: Long S, Pickering LK, Prober CG, editors. Principles and Practice of Pediatric Infectious Diseases: Part 1 Communicable diseases in children. 4th ed. London: Elsevier Inc; 2012. p. 9–24.e3.CrossRef

58.

Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols ( PRISMA-P ) 2015 statement. Syst Rev. 2015;4(1):1–9. https://doi.org/10.1186/2046-4053-4-1.CrossRefPubMedPubMedCentral

59.

Moola S, Munn Z, Tufanaru C, Aromataris E, Sears K, Sfetcu R, Currie M, Qureshi R, Mattis P, Lisy K, Mu P-F. Chapter 7: Systematic reviews of etiology and risk. In: Aromataris E, Munn Z, editors. Joanna Briggs Institute Reviewer's Manual. The Joanna Briggs Institute; 2017. Available from https://reviewersmanual.joannabriggs.org/.

60.

Campbell M, McKenzie JE, Sowden A, Katikireddi SV, Brennan SE, Ellis S, et al. Synthesis without meta-analysis (SWiM) in systematic reviews: Reporting guideline. BMJ. 2020. https://doi.org/10.1136/bmj.l6890.

61.

Nyaga VN, Arbyn M, Aerts M. Metaprop: A Stata command to perform meta-analysis of binomial data. Arch Public Heal. 2014;72(1):1–10.CrossRef

62.

Deeks JJ, Higgins JP, Altman DG. Analysing data and undertaking meta‐analyses. Analysing data and undertaking meta‐analyses. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editors. Cochrane Handbook for Systematic Reviews of Interventions. 2019. https://doi.org/10.1002/9781119536604.ch10.

Title: Modes of transmission and attack rates of group A Streptococcal infection: a protocol for a systematic review and meta-analysis
Authors: Dylan D. Barth
Jessica Daw
Ruomei Xu
Stephanie Enkel
Janessa Pickering
Tracy McRae
Mark E. Engel
Jonathan Carapetis
Rosemary Wyber
Asha C. Bowen
Publication date: 01-12-2021
Publisher: BioMed Central
Keywords: Streptococci
Environmental Medicine
Published in: Systematic Reviews / Issue 1/2021
Electronic ISSN: 2046-4053
DOI: https://doi.org/10.1186/s13643-021-01641-5

At a glance: The STEP trials

Springer Medicine

Modes of transmission and attack rates of group A Streptococcal infection: a protocol for a systematic review and meta-analysis

Abstract

Background

Methods

Discussion

Trial registration

At a glance: The STEP trials

Springer Medicine

Abstract

Background

Methods

Discussion

Trial registration

Please log in to get access to this content

Other articles of this Issue 1/2021

Why do some inter-organisational collaborations in healthcare work when others do not? A realist review

Cost-related medication nonadherence in Canada: a systematic review of prevalence, predictors, and clinical impact

Deciphering the role of physical activity in stress management during a global pandemic in older adult populations: a systematic review protocol

Mapping evidence of depression in HIV-seropositive MSM in sub-Saharan Africa: a scoping review protocol

Effectiveness and harms of clinical decision support systems for referral within chronic pain practice: protocol for a systematic review and meta-analysis

A systematic and meta-analysis review on the diagnostic accuracy of antibodies in the serological diagnosis of COVID-19